Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study

Clinical trial NCT06580444 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06580444
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Use Disorder (AUD)Post Traumatic Stress Disorder (PTSD)

Start date: 2025-07-28
Primary completion: 2027-02-26
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.